Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# # robots.txt # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html User-agent: * # CSS, JS, Images Allow: /core/*.css$ Allow: /core/*.css? Allow: /core/*.js$ Allow: /core/*.js? Allow: /core/*.gif Allow: /core/*.jpg Allow: /core/*.jpeg Allow: /core/*.png Allow: /core/*.svg Allow: /profiles/*.css$ Allow: /profiles/*.css? Allow: /profiles/*.js$ Allow: /profiles/*.js? Allow: /profiles/*.gif Allow: /profiles/*.jpg Allow: /profiles/*.jpeg Allow: /profiles/*.png Allow: /profiles/*.svg # Directories Disallow: /core/ Disallow: /profiles/ |
Title | BioNTech: Be unique, treat |
Description | Harnessing the power of the immune system to develop novel therapies against cancer and infectious At BioNTech we believe that every cancer patient’s treatment should be individualized. Our vision is to provide patient-specific immunotherapies |
Keywords | N/A |
WebSite | events-biontech.de |
Host IP | 52.58.231.225 |
Location | United States |
Euro€500
Zuletzt aktualisiert: 2022-09-15 18:05:32
events-biontech.de hat Semrush globalen Rang von 0. events-biontech.de hat einen geschätzten Wert von € 500, basierend auf seinen geschätzten Werbeeinnahmen. events-biontech.de empfängt jeden Tag ungefähr 500 einzelne Besucher. Sein Webserver befindet sich in United States mit der IP-Adresse 52.58.231.225. Laut SiteAdvisor ist events-biontech.de sicher zu besuchen. |
Kauf-/Verkaufswert | Euro€500 |
Tägliche Werbeeinnahmen | Euro€500 |
Monatlicher Anzeigenumsatz | Euro€500 |
Jährliche Werbeeinnahmen | Euro€500 |
Tägliche eindeutige Besucher | 500 |
Hinweis: Alle Traffic- und Einnahmenwerte sind Schätzungen. |
Host | Type | TTL | Data |
events-biontech.de. | A | 599 | IP: 52.58.231.225 |
events-biontech.de. | NS | 86400 | NS Record: ns.udag.de. |
events-biontech.de. | NS | 86400 | NS Record: ns.udag.org. |
events-biontech.de. | NS | 86400 | NS Record: ns.udag.net. |
events-biontech.de. | MX | 3600 | MX Record: 20 mx01.udag.de. |
events-biontech.de. | MX | 3600 | MX Record: 10 mx00.udag.de. |
events-biontech.de. | TXT | 600 | TXT Record: v=spf1 include:amazonses.com include:_smtp.udag.de ~all |
We aspire to individualize cancer medicine EN | DE Select your language English German Top Bar Menu Investors & Media Careers Connect Healthcare Professionals Home Our DNA Our DNA - Child Our vision Leadership Responsibility Collaborators Services Locations BioNTech US How We Translate How we translate - Child The BioNTech approach mRNA therapeutics Engineered cell therapies Antibodies Small molecule immunomodulators Manufacturing Intellectual property Science Science - Child Individualized cancer medicine Pipeline Platforms Publications For Patients For patients - Child Info & resources Clinical trials COVID-19 COVID-19 Child COVID-19 Portal COVID-19 Disease mRNA Vaccines Project Lightspeed Frequently asked questions Investors & Media Careers Connect Healthcare Professionals EN | DE Select your language English German Follow us Search Search OUR VISION Harnessing the power of the immune system to develop novel therapies against cancer and infectious diseases Learn more mRNA |
HTTP/1.1 200 OK Server: nginx/1.11.9 Date: Fri, 24 Dec 2021 13:10:36 GMT Content-Type: text/html; charset=UTF-8 Connection: keep-alive Vary: Accept-Encoding Access-Control-Allow-Origin: * Access-Control-Allow-Methods: GET, POST, OPTIONS Cache-Control: no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0 |